NASDAQ: NGNE 31.15%
Neurogene Shares Rally on FDA Breakthrough Therapy Designation for Rett Syndrome Therapy
NASDAQ: BYND 32.83%
Expected US Company Earnings on Wednesday, February 25th, 2026
NASDAQ: CDIO 32.65%
BioMedNewsBreaks - Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) Schedules Investor Conference Call for Feb. 19, 2026
NASDAQ: ENSC 73.31%
Expected US Company Earnings on Tuesday, November 11th, 2025
NASDAQ: PRAA 32.17%
PRA Group (PRAA) Q4 2025 Earnings Call Transcript
NYSE: KORE 77.39%
KORE Reports Third Quarter 2025 Results
NYSE: NGNE 32.83%
NYSE: BYND 32.83%
NYSE: CDIO 32.83%
NYSE: ENSC 32.83%
NYSE: PRAA 32.83%
